# BioImpact

> BioImpact is a VC fund in Shinjuku backing Medical and Therapeutics. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Shinjuku, Japan
- Total investments: 3
- Last investment: Aug 2022
- Lead investor: 0%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/bio_impact
- Website: https://research-er.jp/
- Facebook: https://www.facebook.com/bioimpact.jp

BioImpact is a VC fund in Shinjuku focused on Medical and Therapeutics. BioImpact supports the collection of information such as statistical data, and more effective information transmission centered on “research”. The company is a web production company whose business domain is the research industry. Researchers' results reports are published nationwide on a daily basis, but the impact is difficult to convey tothe world and is difficult to reach. BioImpact provides a variety of services to connect companies, researchers, centering on the four businesses of media, production, sales or sales support, and database”.

## Contacts

5 contacts available for BioImpact. Shizune tracks 1 team members at BioImpact. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bioimpact?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Therapeutics | 1 | 33% |
| Biotechnology | 1 | 33% |
| Pharmaceutical | 1 | 33% |
| Information Technology | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series B | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Japan | 1 | 33% |
| United States | 1 | 33% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Junichi Sugihara | President and CEO | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Orna Therapeutics | Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. | $221M | Series B | Aug 16, 2022 |  |
| Orna Therapeutics | Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way we treat disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions. | $221M | Series B | Aug 16, 2022 |  |
| Inner Resource | Inner Resource is a cloud purchasing system specialized in research industry. | $11.3M | Seed | Feb 13, 2019 |  |

3 of 3 investments shown.

## Co-investors
- [Merck](https://shizune.co/investors/profile/merck-kgaa) — VC Fund, 2 deals together
- [MPM Capital](https://shizune.co/investors/profile/mpm-capital) — VC Fund, 2 deals together
- [ANRI](https://shizune.co/investors/profile/anri) — VC Fund, 1 deal together
- [Archetype Ventures](https://shizune.co/investors/profile/archetype-ventures) — VC Fund, 1 deal together
- [DNX Ventures](https://shizune.co/investors/profile/dnx-ventures) — VC Fund, 1 deal together
- [Leave a Nest](https://shizune.co/investors/profile/leave-a-nest-co-ltd) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does BioImpact invest in?

BioImpact invests primarily in Medical, Therapeutics and Biotechnology startups, most often at Seed and Series B stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BioImpact?

Public channels for BioImpact include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BioImpact?

The team at BioImpact includes Junichi Sugihara (President and CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co